Skip to main content

Table 1 Distribution of bacterial species among ESBL-E, pAmpC-E, CIP-RE and CIRE isolates, Northern Cyprus, 2017

From: Extended-spectrum β-lactamase, plasmid-mediated AmpC β-lactamase, fluoroquinolone resistance, and decreased susceptibility to carbapenems in Enterobacteriaceae: fecal carriage rates and associated risk factors in the community of Northern Cyprus

Bacterial species

ESBL-E

pAmpC-E

CIP-RE

CIRE

n/N (%)a

n/N (%)a

n/N (%)a

n/N (%)a

Escherichia coli

101/107 (94.4)

13/15 (86.7)

51/51 (100.0)

2/6 (33.3)

Klebsiella pneumoniae

3/107 (2.8)

2/15 (13.3)

2/6 (33.3)

Klebsiella oxytoca

1/6 (16.7)

Enterobacter cloacae

1/107 (0.9)

Enterobacter aerogenes

1/107 (0.9)

1/6 (16.7)

Providencia rettgeri

1/107 (0.9)

Total n/N (%)b

107/500 (21.4)

15/500 (3.0)

51/500 (10.2)

6/500 (1.2)

  1. Abbreviations: ESBL-E Extended-spectrum β-lactamase-producing Enterobacteriaceae; pAmpC-E plasmid-mediated AmpC β-lactamase-producing Enterobacteriaceae, CIP-RE Ciprofloxacin-resistant Enterobacteriaceae, CIRE Carbapenem-intermediate or -resistant Enterobacteriaceae
  2. aIndicates the percentage of bacterial species among ESBL-E (N = 107), pAmpC-E (N = 15), CIP-RE (N = 51), or CIRE (N = 6) isolates
  3. bIndicates the percentage of ESBL-E, pAmpC-E, CIP-RE and CIRE isolates according to 500 samples